(Q51175571)

31 March 2018

title

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. (English)

1 reference

31 March 2018

1 reference

1 reference

3

Lyn Finelli

1 reference

31 March 2018

2

Martin I Meltzer

1 reference

31 March 2018

author name string

Carrie Reed

series ordinal

1

1 reference

31 March 2018

Anthony Fiore

series ordinal

4

1 reference

31 March 2018

language of work or name

English

0 references

publication date

5 January 2012

1 reference

31 March 2018

published in

Vaccine

1 reference

31 March 2018

volume

30

1 reference

31 March 2018

issue

11

1 reference

31 March 2018

page(s)

1993-1998

1 reference

31 March 2018

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Seasonal influenza in the United States, France, and Australia: transmission and prospects for control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Comparative efficacy of inactivated and live attenuated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

Genetic and phenotypic analysis of reassortants of high growth and low growth strains of influenza B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.098

10.1016/J.VACCINE.2011.12.098

7 January 2021

Identifiers

DOI

1 reference

31 March 2018

PubMed ID

22226861

1 reference

31 March 2018